Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines

PLoS Neglected Tropical Diseases

Volumn 8, Issue 9, 2014, Pages

  Vieira Machado, Alessandra A ^a   Estevan, Anderson Oliveira ^a   Sales, Antonio ^b   Brabes, Kelly Cristina da Silva ^a   Croda, Júlio ^a   Negrão, Fábio Juliano ^a  

^a UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^b UNIVERSIDADE ESTADUAL DE MATO GROSSO DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAZIL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DENGUE; DISEASE CLASSIFICATION; FEMALE; GROSS NATIONAL PRODUCT; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; WORLD HEALTH ORGANIZATION; AGED; COST; ECONOMICS; EPIDEMIC; HEALTH CARE COST; HEALTH CARE DELIVERY; HOSPITALIZATION; PUBLIC HEALTH;

AGED; BRAZIL; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DENGUE; DISEASE OUTBREAKS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; RETROSPECTIVE STUDIES;

EID: 84907584493     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003104     Document Type: Article

References (43)

1. Paho (2012) Number of Reported Cases of Dengue and Figures for 2010 (to week noted by each country). Pan American Health Organization
2. WHO (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: Geneva: World Health Organization. 147 p.
3. Halasa YA, Shepard DS, Zeng W, (2012) Economic Cost of Dengue in Puerto Rico. The American Journal of Tropical Medicine and Hygiene 86: 745–752.
4. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, et al. (2009) Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg 80: 846–855.
5. Torres JR, Castro J, (2007) The health and economic impact of dengue in Latin America. Cadernos de Saúde Pública 23: S23–S31.
6. Klungthong C, Zhang C, Mammen MP, JrUbol S, Holmes EC, (2004) The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 329: 168–179.
7. Weaver SC, Vasilakis N, (2009) Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infection, Genetics and Evolution 9: 523–540.
8. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7–16.
9. Thomas L, Kaidomar S, Kerob-Bauchet B, Moravie V, Brouste Y, et al. (2009) Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion 49: 1400–1411.
10. Whitehorn J, Roche RR, Guzman MG, Martinez E, Villamil Gomez W, et al. (2012) Prophylactic Platelets in Dengue: Survey Responses Highlight Lack of an Evidence Base. PLoS Negl Trop Dis 6: e1716.
11. Brasil (2012) Casos confirmados de FHD, segundo ano de confirmação. Brasil, Grandes Regiões e Unidades Federadas, 1990–1991, 1994–2011. Brasília: Ministério da saúde.
12. DOURADOS (2011) Secretaria Municipal de Saúde: Relatório de Gestão 2010. Dourados: SEMS.
13. IBGE (2010) Censo demográfico Brasileiro 2010. IBGE - Instituto Brasileiro de Geografia e Estatística. 2010 ed: Brasil.
14. Byford S, Torgerson DJ, Raftery J, (2000) Economic note: cost of illness studies. BMJ 320: 1335.
15. Drummond MF, Sculpher MJ, Torrance GW (2005) Methods for the Economic Evaluation of Health Care Programs: Oxford University Press.
16. Grosse SD, Krueger KV, (2011) The Income-Based Human Capital Valuation Methods in Public Health Economics Used by Forensic Economics. Journal of Forensic Economics 22: 43–57.
17. DOURADOS M, (2010) Agravo Dengue. SINAN - sistema nacional de agravos notificáveis Dourados-MS: Secretaria Municipal de saúde-Setor de vigilância Epidemiológica.
18. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, et al. (2002) Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 40: 376–381.
19. Kumarasamy V, Chua SK, Hassan Z, Wahab AH, Chem YK, et al. (2007) Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med J 48: 669–673.
20. Munoz-Jordan JL, Collins CS, Vergne E, Santiago GA, Petersen L, et al. (2009) Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol 47: 927–931.
21. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, et al. (2011) Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health 16: 936–948.
22. Barniol J, Gaczkowski R, Barbato E, da Cunha R, Salgado D, et al. (2011) Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infectious Diseases 11: 106.
23. Narvaez F, Gutierrez G, Pérez MA, Elizondo D, Nuñez A, et al. (2011) Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity. PLoS Negl Trop Dis 5: e1397.
24. Hodgson TA, Meiners MR, (1982) Cost-of-Illness Methodology: A Guide to Current Practices and Procedures. The Milbank Memorial Fund Quarterly Health and Society 60: 429–462.
25. Paim J, Travassos C, Almeida C, Bahia L, Macinko J, (2011) The Brazilian health system: history, advances, and challenges. The Lancet 377: 1778–1797.
26. Brasil (2012) Caderno de Informação da Saúde Suplementar: beneficiários, operadoras e planos. Rio de Janeiro: Ministério da Saúde - Agência Nacional de saúde Suplementar (ANS). 54 p.
27. Brasil (2012) Valores médios das internações por dengue pelo SUS. Brasil - 2010. Ministério da Saúde - Sistema de Informações Hospitalares do SUS (SIH/SUS). 2012 ed.
28. Brasil (2009) A implementação de diretrizes clínicas na atenção à saúde: experiências internacionais e o caso da saúde suplementar no Brasil. Rio de Janeiro: Ministério da Saúde/Agência Nacional de Saúde Suplementar – ANS. 132 p.
29. Nogueira LdS, Sousa RMCd, Padilha KG, Koike KM, (2012) Características clínicas e gravidade de pacientes internados em UTIs públicas e privadas. Texto & Contexto - Enfermagem 21: 59–67.
30. Balassiano M, Seabra AAd, Lemos AH, (2005) Escolaridade, salários e empregabilidade: tem razão a teoria do capital humano? Revista de Administração Contemporânea 9: 31–52.
31. da Silva ZP, Ribeiro MC, Barata RB, de Almeida MF, (2011) [Socio-demographic profile and utilization patterns of the public healthcare system (SUS), 2003–2008]. Cien Saude Colet 16: 3807–3816.
32. Ribeiro MCSdA, Barata RB, Almeida MFd, Silva ZPd, (2006) Perfil sociodemográfico e padrão de utilização de serviços de saúde para usuários e não-usuários do SUS - PNAD 2003. Ciência & Saúde Coletiva 11: 1011–1022.
33. Freitas PdSS, Schwartz TD, Ribeiro CDM, Franco TB, Maciel ELN, et al. (2011) A percepção dos usuários sobre a oferta de programas de promoção da saúde e prevenção de doenças: o caso de uma operadora de autogestão. Physis: Revista de Saúde Coletiva 21: 449–459.
34. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH, (2011) Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84: 200–207.
35. Grol R, Grimshaw J, (2003) From best evidence to best practice: effective implementation of change in patients' care. Lancet 362: 1225–1230.
36. Schuster MA, McGlynn EA, Brook RH, (1998) How good is the quality of health care in the United States? Milbank Q 76: 517–509.
37. Shojania KG, Forster AJ, (2008) Hospital mortality: when failure is not a good measure of success. Canadian Medical Association Journal 179: 153–157.
38. Wiersema A, Bruijninckx C, Reijnen M, Vos J, Van Delden O, et al. (2013) Perioperative prophylactic antithrombotic strategies in vascular surgery: current practice in the Netherlands. J Cardiovasc Surg (Torino)
39. Kumar ND, Tomar V, Singh B, Kela K, (2000) Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol 43: 55–60.
40. Lye DC, Lee VJ, Sun Y, Leo YS, (2009) Lack of Efficacy of Prophylactic Platelet Transfusion for Severe Thrombocytopenia in Adults with Acute Uncomplicated Dengue Infection. Clinical Infectious Diseases 48: 1262–1265.
41. Pallavi P, Ganesh CK, Jayashree K, Manjunath GV, (2011) Unfurling the rationale use of platelet transfusion in dengue Fever. Indian J Hematol Blood Transfus 27: 70–74.
42. Cavalcanti LPGML, Lustosa GP, Fortes MC, Mota DAM, Lima AAB, Coelho ICB, Mourão MPG, (2014) Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil. Mem Inst Oswaldo Cruz 109 (1) 93–98.
43. Lima FR, Croda MG, Muniz DA, Gomes IT, Soares KRdM, et al. (2013) Evaluation of the traditional and revised world health organization classifications of dengue cases in Brazil. Clinics 68: 1299–1304.